Rafat Ali Siddiqui

Prof. Dr. Rafat Ali Siddiqui

Virginia State University
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Reproduction Nutrition Development
Verified
Journal Article
Open access
PDF file
WSWilliam Stillwell
William Stillwell
SSSaame Raza Shaikh
Saame Raza Shaikh
MZMustafa Zerouga
Mustafa Zerouga
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
SWStephen R. Wassall
Stephen R. Wassall
Reproduction Nutrition Development, formerly Annales de Biologie Animale Biochimie Biophysique

27 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
SPSafiullah Pathan
Safiullah Pathan
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
Quinoa (Chenopodium quinoa Willd.) is a nutrient-rich grain native to South America and eaten worldwide as a healthy food, sometimes even referred to as a ”superfood”. Like quinoa grains, quinoa greens (green leaves, sprouts, and microgreens) are also rich in nutrients and have health promoting properties such as being antimicrobial, anticancer, antidiabetic, antioxidant, antiobesity, and cardio-beneficial. Quinoa greens are gluten-free and provide an excellent source of protein, amino acids, essential minerals, and omega-3 fatty acids. Quinoa greens represent a promising value-added vegetable that could resolve malnutrition problems and contribute to food and nutritional security. The greens can be grown year-round (in the field, high tunnel, and greenhouse) and have short growth durations. In addition, quinoa is salt-, drought-, and cold-tolerant and requires little fertilizer and water to grow. Nevertheless, consumption of quinoa greens as leafy vegetables is uncommon. To date, only a few researchers have investigated the nutritional properties, phytochemical composition, and human health benefits of quinoa greens. We undertook a comprehensive review of the literature on quinoa greens to explore their nutritional and functional significance to human health and to bring awareness to their use in human diets.

1 December 2010 in Journal of Lipid Research
Verified
Journal Article
Open access
KHKevin A. Harvey
Kevin A. Harvey
CWCandace L. Walker
Candace L. Walker
ZXZhidong Xu
Zhidong Xu
PWPhillip Whitley
Phillip Whitley
TPThomas M. Pavlina
Thomas M. Pavlina
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
Saturated fatty acids (SFAs), significant components of both enteral/parenteral nutritional formulations (including diet), are linked to cardiovascular disease complications, such as atherosclerosis. We investigated whether oleic acid (C18:1n-9) reduces the growth inhibitory and pro-inflammatory effects of the stearic acid (C18:0) in human aortic endothelial cells (HAEC). Stearic acid induced growth inhibition at concentrations less than 50 μM, whereas higher concentrations invoked cytotoxicity. Stearic acid-induced growth inhibition and cytotoxic effects were eradicated upon cosupplementation with oleic acid (25 μM). Oleic acid (as low as 5 μM) also inhibited the stearic acid-induced increase in intercellular adhesion molecule-1 (ICAM-1) expression. Stearic acid-induced phosphorylation of nuclear factor-kappa B (NF-κB), a transcriptional regulator of ICAM-1, was also reduced by oleic acid. HAECs supplemented with either stearic or oleic acid resulted in cellular incorporation of C18:0 and C18:1n-9, respectively. Stearic acid primarily incorporated into phospholipids without increasing the total fatty acid content in HAECs. In contrast, oleic acid, with or without stearic acid, incorporated into both phospholipids and triglycerides, with a significant increase in total fatty acid amounts in triglycerides. Our data suggest that oleic acid has the ability to reduce the inflammatory effects of long-chain SFAs in HAECs through reducing cellular stearic acid incorporation and NF-κB activation.

7 June 2005 in Breast Cancer Research
Verified
Journal Article
Open access
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
MZMustapha Zerouga
Mustapha Zerouga
MWMin Wu
Min Wu
ACAlicia Castillo
Alicia Castillo
KHKevin Harvey
Kevin Harvey
WSWilliam Stillwell
William Stillwell
Introduction: Epidemiological evidence strongly links fish oil, which is rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), with low incidences of several types of cancer. The inhibitory effects of omega-3 polyunsaturated fatty acids on cancer development and progression are supported by studies with cultured cells and animal models. Propofol (2,6-diisopropylphenol) is the most extensively used general anesthetic–sedative agent employed today and is nontoxic to humans at high levels (50 μg/ml). Clinically relevant concentrations of propofol (3 to 8 μg/ml; 20 to 50 μM) have also been reported to have anticancer activities. The present study describes the synthesis, purification, characterization and evaluation of two novel anticancer conjugates, propofol-docosahexaenoate (propofol-DHA) and propofol-eicosapentaenoate (propofol-EPA). Methods: The conjugates linking an omega-3 fatty acid, either DHA or EPA, with propofol were synthesized and tested for their effects on migration, adhesion and apoptosis on MDA-MB-231 breast cancer cells. Results: At low concentrations (25 μM), DHA, EPA or propofol alone or in combination had minimal effect on cell adhesion to vitronectin, cell migration against serum and the induction of apoptosis (only 5 to 15% of the cells became apoptotic). In contrast, the propofol-DHA or propofol-EPA conjugates significantly inhibited cell adhesion (15 to 30%) and migration (about 50%) and induced apoptosis (about 40%) in breast cancer cells. Conclusion: These results suggest that the novel propofol-DHA and propofol-EPA conjugates reported here may be useful for the treatment of breast cancer.

14 September 2005 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MWMin Wu
Min Wu
KHKevin A. Harvey
Kevin A. Harvey
NRNargiz Ruzmetov
Nargiz Ruzmetov
ZWZachary R. Welch
Zachary R. Welch
LSLaura Sech
Laura Sech
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
The effect of fish oils and their active omega‐3 fatty acid constituents, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), were investigated on breast cancer growth. In in vivo experiments, mice were fed diets that were rich in either omega‐3 (fish oil) or omega‐6 (corn oil) fatty acids. Three weeks after implantation of MDA‐MB‐231 breast cancer cells, the tumor volume and weight were significantly lower (p < 0.05) for mice fed the omega‐3 diets compared to those fed the omega‐6 diets. Dietary fish oil also caused a 40% (p < 0.05) increase in neutral sphingomyelinase (N‐SMYase) activity in the tumors. The tumor tissues from fish oil‐fed animals expressed elevated p21 (waf1/cip1) mRNA, whereas tumor tissues from corn oil‐fed animals exhibited undetectable levels of p21 expression. In in vitro experiments, at concentrations as low as 25 μM, DHA and EPA inhibited the growth of cultured MDA‐MB‐231 cells in a dose‐dependent manner by 20–25% (p < 0.05). N‐SMYase activity was also increased by 30–40% (p < 0.05) in the DHA‐ or EPA‐treated cells in which an increase in ceramide formation was observed. DHA and EPA were both observed to enhance membrane bleb formation and also to induce the expression of p21. Omega‐3 fatty acids‐induced bleb formation and p21 expression were inhibited by the N‐SMYase inhibitor GW4869, which also inhibited apoptosis by approximately 40% (p < 0.05). The results suggest that inhibition of breast cancer growth in nude mice by dietary fish oil and inhibition of breast cancer cell growth in culture by treatment with DHA and EPA is mediated by activation of N‐SMYase.

1 October 2004 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Rafat Ali SiddiquiRafat Ali Siddiqui
Rafat Ali Siddiqui
SSSaame R. Shaikh
Saame R. Shaikh
LSLaura A. Sech
Laura A. Sech
HYHeidi R. Yount
Heidi R. Yount
WSWilliam Stillwell
William Stillwell
GZGary P. Zaloga
Gary P. Zaloga
Epidemiological evidence has established that ingestion of long-chain polyunsaturated omega-3 fatty acids (ω-3 PUFAs), abundant in fish oils, have profound effects on many human disorders and diseases, including cardiovascular disease and cancer. Here we briefly review the dietary recommendations and the food sources that are naturally enriched by these fatty acids. There are also a number of products including eggs, bread, and cereals available to supplement ω-3 fatty acid dietary intake. Some of these supplements are proposed to aid different pathological conditions. While the beneficial effects of omega-3 fatty acids can no longer be doubted, their molecular mechanism of action remains elusive. Without question, the action of omega-3 fatty acids is complex and involves a number of integrated signaling pathways. This review focuses on one of the possible cellular mechanisms by which the ω-3 PUFAs, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may function. Studies with cancer cells suggest that DHA induces cell cycle arrest and apoptosis by activating protein phosphatases, leading to dephosphorylation of retinoblastoma protein (pRB). Protein phosphatases are also involved with the protein Bcl2, which regulates the release of cytochrome c from mitochondria, and eventually, activation of the apoptotic enzyme caspase 3.